Sunday, January 16, 2022

Report: FDA to fully approve Pfizer vaccine on Monday

By Katanga Johnson, Michael Erman and Manojna Maddipatla | Reuters

WASHINGTON – The US Food and Drug Administration is aiming for full approval of Pfizer’s COVID-19 vaccine on Monday, The New York Times reported on Friday.

Regulators were aiming to complete the process by Friday, but were still working through “a substantial amount of paperwork and negotiations with the company,” the Times said, citing people familiar with the plan, who are not aware of its were not authorized to speak publicly about

The agency declined to comment.

The report said it had set an unofficial deadline for approval around Labor Day on September 6.

The approval could boost a vaccination campaign by assuring more illiterate Americans that Pfizer’s shot is safe and effective and make local officials more comfortable implementing vaccine mandates.

The US military is expected to vaccinate service members soon after Pfizer has authorized the shot and other major US employers can follow suit.

Vaccine hesitation has been a major obstacle to the White House’s goal of vaccinating all eligible Americans against the coronavirus.

Only about 60% of adults aged 18 and over have been fully vaccinated, while the new delta version of COVID-19 has contributed to the rise in cases.

Pfizer’s full approval of the shot will make it easier for physicians to prescribe a third booster shot for people who may benefit from additional doses.

The FDA has authorized Pfizer’s shots as a booster for people with weakened immune systems, but the White House plans to introduce them more widely in the coming months.

Nation World News Desk
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news
- Advertisement -